| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |